Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes

NCT00855166 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Dapagliflozin
DRUG: Metformin
DRUG: Sitagliptin
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]